KUN-CHIEH CHENGEE-CHEN CHANG2026-10-162026-10-162023-01-01Pure ID: 15175374Pure UUID: 969aea49-7aab-4fa1-bf0a-a41ccde1518010.1007/s11523-022-00928-4https://www.scopus.com/pages/publications/85141404276https://scholars.csmu.edu.tw/handle/123456789/29022The article The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non- Small Cell Lung Cancer in Taiwan, written by Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, Kang-Yi Su, Sung-Liang Yu, Jeremy J. W. Chen and Gee-Chen Chang, was originally published electronically in SpringerLink on 23 April 2022 without open access.2enjournal article